Loading...
MVC logo

Metrovacesa S.A.BME:MVC 株式レポート

時価総額 €1.6b
株価
€10.74
€10.81
0.6% 割安 内在価値ディスカウント
1Y-1.5%
7D-8.5%
1D
ポートフォリオ価値
表示

Metrovacesa S.A.

BME:MVC 株式レポート

時価総額:€1.6b

Metrovacesa(MVC)株式概要

メトロバセサS.A.はスペインで不動産開発会社として営業している。 詳細

MVC ファンダメンタル分析
スノーフレーク・スコア
評価2/6
将来の成長0/6
過去の実績4/6
財務の健全性5/6
配当金2/6

MVC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Metrovacesa S.A. 競合他社

価格と性能

株価の高値、安値、推移の概要Metrovacesa
過去の株価
現在の株価€10.74
52週高値€13.50
52週安値€8.82
ベータ0.71
1ヶ月の変化-8.83%
3ヶ月変化-1.92%
1年変化-1.47%
3年間の変化54.31%
5年間の変化45.73%
IPOからの変化-32.88%

最新ニュース

ナラティブの更新 May 02

MVC: Slightly Higher Required Return And Rich P/E Will Constrain Future Upside

Analysts have kept their average price target for Metrovacesa broadly steady around €10.81, citing only slight shifts in discount rate, profit margin assumptions and future P/E expectations rather than any major change in the investment case. Valuation Changes Fair Value: The €10.81 fair value estimate is unchanged, indicating a stable central valuation point in the model.
ナラティブの更新 Apr 17

MVC: Higher Required Return And Rich P/E Will Pressure Future Returns

Analysts have kept their price target for Metrovacesa broadly unchanged at around €10.81 per share. The latest revisions reflect only very small model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their core view.
ナラティブの更新 Apr 03

MVC: Stable Assumptions And Discount Rate Tweaks Will Guide Future Returns

Analysts keep their Metrovacesa price target steady at €10.81, indicating largely unchanged assumptions on fair value, growth, margins, and future P/E, with only minor adjustments to discount rates and long-term expectations. Valuation Changes Fair Value: €10.81 per share is unchanged, suggesting the core view of what the stock is worth on a fundamental basis remains the same.

Recent updates

ナラティブの更新 May 02

MVC: Slightly Higher Required Return And Rich P/E Will Constrain Future Upside

Analysts have kept their average price target for Metrovacesa broadly steady around €10.81, citing only slight shifts in discount rate, profit margin assumptions and future P/E expectations rather than any major change in the investment case. Valuation Changes Fair Value: The €10.81 fair value estimate is unchanged, indicating a stable central valuation point in the model.
ナラティブの更新 Apr 17

MVC: Higher Required Return And Rich P/E Will Pressure Future Returns

Analysts have kept their price target for Metrovacesa broadly unchanged at around €10.81 per share. The latest revisions reflect only very small model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their core view.
ナラティブの更新 Apr 03

MVC: Stable Assumptions And Discount Rate Tweaks Will Guide Future Returns

Analysts keep their Metrovacesa price target steady at €10.81, indicating largely unchanged assumptions on fair value, growth, margins, and future P/E, with only minor adjustments to discount rates and long-term expectations. Valuation Changes Fair Value: €10.81 per share is unchanged, suggesting the core view of what the stock is worth on a fundamental basis remains the same.
ナラティブの更新 Mar 20

MVC: Dividend Outlook And Revised Assumptions Will Shape Future Return Balance

Analysts now set their fair value estimate for Metrovacesa at €10.81 per share, up from €10.63. This reflects updated assumptions around the discount rate, revenue growth, profit margin and future P/E.
ナラティブの更新 Mar 06

MVC: Lower Growth Assumptions And Elevated P/E Will Sustain Bearish View

Analysts have modestly lowered their price target on Metrovacesa to €9.30, citing updated assumptions for revenue growth, profit margins and the future P/E multiple, while keeping their fair value estimate unchanged at €9.30. Valuation Changes Fair Value: The fair value estimate is unchanged at €9.30 per share, indicating no revision to the overall valuation outcome.
ナラティブの更新 Feb 20

MVC: Dividend Outlook And Updated Assumptions Will Shape Future Return Balance

Analysts have slightly trimmed their fair value estimate for Metrovacesa from €10.83 to €10.63, citing updated assumptions around discount rates, expected revenue growth, margins and future P/E levels. Valuation Changes Fair Value: Trimmed slightly from €10.83 to €10.63 per share.
ナラティブの更新 Feb 06

MVC: Lower Discount Rate And High P/E Will Sustain Bearish View

Analysts have slightly raised their price target on Metrovacesa, citing updated assumptions for the discount rate, revenue growth, profit margins and future P/E, which together indicate a modestly higher fair value per share in euro terms. Valuation Changes Fair Value: unchanged at €9.30 per share.
ナラティブの更新 Jan 23

MVC: Dividend Reserve Plans And P/E Revisions Will Guide Cautious Outlook

Analysts have maintained their Metrovacesa fair value target at €9.30, citing a combination of updated assumptions that include slightly lower discount rates, higher revenue growth expectations, softer profit margins and a higher future P/E multiple in their latest models. What's in the News Metrovacesa has scheduled a Special and Extraordinary Shareholders Meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (Key Developments).
ナラティブの更新 Jan 08

MVC: Dividend Proposal At Extraordinary Meeting Will Support Bullish Thesis

Analysts have revised their price target on Metrovacesa from €11.80 to €13.10, citing updated assumptions around discount rates, revenue growth, profit margins, and the future P/E multiple. What's in the News Metrovacesa has scheduled a Special and Extraordinary Shareholders Meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (calle principe de vergara 187, plaza de rodrigo uria, madrid) (Key Developments) The meeting agenda includes a proposal to discuss the distribution of dividends from freely distributable reserves, which may be relevant if you are focusing on potential cash returns to shareholders (Key Developments) The notice also refers to discussion of other matters at the meeting, indicating that additional shareholder topics could be addressed beyond dividends (Key Developments) Valuation Changes Fair Value Estimate was revised from €11.80 to €13.10, indicating a higher assessed value per share.
ナラティブの更新 Dec 24

MVC: Dividend Reserve Plans Will Shape A Cautious Medium-Term Outlook

Analysts have raised their price target on Metrovacesa from €6.50 to €9.30, citing higher expected revenue growth, improved profit margins, and a modestly richer future P/E multiple, despite a slightly higher discount rate. What's in the News Metrovacesa has called a special shareholders meeting for November 25, 2025, at 13:00 CET in Madrid to address key corporate matters.
分析記事 Dec 20

Metrovacesa S.A. (BME:MVC) Shares Could Be 23% Below Their Intrinsic Value Estimate

Key Insights Metrovacesa's estimated fair value is €11.52 based on 2 Stage Free Cash Flow to Equity Current share price...
ナラティブの更新 Dec 10

MVC: Dividend Decision And Revised Outlook Will Shape Balanced Return Prospects

Analysts have raised their price target on Metrovacesa from €9.81 to €10.83, citing a higher long term fair value despite moderating assumptions for revenue growth, profit margins and future earnings multiples. What's in the News Metrovacesa has scheduled a special and extraordinary shareholders meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (Key Developments) The main agenda item for the upcoming meeting is the potential distribution of dividends from freely distributable reserves, which could affect shareholder returns policy (Key Developments) Shareholders will also address other unspecified matters at the meeting, leaving scope for additional corporate or capital structure decisions (Key Developments) Valuation Changes Fair Value: raised slightly from €9.81 to €10.83 per share, reflecting a modest uplift in long term valuation.
分析記事 Oct 02

Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Metrovacesa S.A. ( BME:MVC ), is not the largest company out there, but it had a relatively subdued couple of weeks in...
分析記事 Jul 25

Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €12.58 Metrovacesa's €10.15...
分析記事 May 04

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 Apr 12

Are Investors Undervaluing Metrovacesa S.A. (BME:MVC) By 40%?

Key Insights The projected fair value for Metrovacesa is €16.96 based on 2 Stage Free Cash Flow to Equity Metrovacesa...
分析記事 Feb 26

Metrovacesa's (BME:MVC) Performance Is Even Better Than Its Earnings Suggest

Even though Metrovacesa S.A.'s ( BME:MVC ) recent earnings release was robust, the market didn't seem to notice. We...
User avatar
新しいナラティブ Feb 19

Will Leverage Undersupplied Spanish Housing Market For Future Opportunities

High presales coverage allows focus on margin maximization, boosting future net margins amid an undersupplied market.
分析記事 Feb 07

Is It Time To Consider Buying Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it maintained its current share price...
分析記事 Dec 13

An Intrinsic Calculation For Metrovacesa S.A. (BME:MVC) Suggests It's 44% Undervalued

Key Insights Metrovacesa's estimated fair value is €16.39 based on 2 Stage Free Cash Flow to Equity Metrovacesa's €9.13...
分析記事 Sep 12

Estimating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights The projected fair value for Metrovacesa is €9.93 based on 2 Stage Free Cash Flow to Equity Metrovacesa's...
分析記事 Aug 01

We Think Metrovacesa's (BME:MVC) Profit Is Only A Baseline For What They Can Achieve

The subdued stock price reaction suggests that Metrovacesa S.A.'s ( BME:MVC ) strong earnings didn't offer any...
分析記事 Jul 17

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it saw significant share price...
分析記事 May 28

A Look At The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €9.31 Current share price...
分析記事 May 01

We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 Mar 27

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it received a lot of attention from a...
分析記事 Feb 12

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights The projected fair value for Metrovacesa is €9.08 based on 2 Stage Free Cash Flow to Equity Current share...
分析記事 Nov 05

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 Jul 05

These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 May 21

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not be the most widely known stock at the moment, it saw significant share...
分析記事 Apr 19

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €7.36 Current share price...
分析記事 Dec 02

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 Sep 23

Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not be the most widely known stock at the moment, it received a lot of...
分析記事 May 19

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Does the May share price for Metrovacesa S.A. ( BME:MVC ) reflect what it's really worth? Today, we will estimate the...
分析記事 Mar 05

Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality

Metrovacesa S.A. ( BME:MVC ) just reported healthy earnings but the stock price didn't move much. We think that...
分析記事 Feb 16

Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
分析記事 Oct 05

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 Jul 02

Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?

Today we will run through one way of estimating the intrinsic value of Metrovacesa S.A. ( BME:MVC ) by projecting its...
分析記事 May 06

Is Metrovacesa (BME:MVC) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 Apr 06

Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?

Is Metrovacesa S.A. ( BME:MVC ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...
分析記事 Mar 15

Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years

Metrovacesa S.A. ( BME:MVC ) shareholders should be happy to see the share price up 12% in the last month. But that...
分析記事 Feb 16

Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven

We feel now is a pretty good time to analyse Metrovacesa S.A.'s ( BME:MVC ) business as it appears the company may be...
分析記事 Jan 26

When Should You Buy Metrovacesa S.A. (BME:MVC)?

Metrovacesa S.A. ( BME:MVC ), might not be a large cap stock, but it led the BME gainers with a relatively large price...
分析記事 Jan 05

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

In this article we are going to estimate the intrinsic value of Metrovacesa S.A. ( BME:MVC ) by taking the expected...
分析記事 Dec 14

If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%

Metrovacesa S.A. ( BME:MVC ) shareholders should be happy to see the share price up 11% in the last month. But that...

株主還元

MVCES Real EstateES 市場
7D-8.5%-2.7%1.0%
1Y-1.5%0.1%22.7%

業界別リターン: MVC過去 1 年間で0.1 % の収益を上げたSpanish Real Estate業界を下回りました。

リターン対市場: MVCは、過去 1 年間で22.7 % のリターンを上げたSpanish市場を下回りました。

価格変動

Is MVC's price volatile compared to industry and market?
MVC volatility
MVC Average Weekly Movement5.6%
Real Estate Industry Average Movement3.9%
Market Average Movement3.9%
10% most volatile stocks in ES Market6.7%
10% least volatile stocks in ES Market0.9%

安定した株価: MVCの株価は、 Spanish市場と比較して過去 3 か月間で変動しています。

時間の経過による変動: MVCの weekly volatility ( 6% ) は過去 1 年間安定していますが、依然としてSpanishの株式の 75% よりも高くなっています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
1918214Jorge de Leza Eguigurenwww.metrovacesa.com

メトロバセサS A.はスペインで不動産開発会社として営業している。同社は住宅および商業施設の開発・販売、土地の販売を行っている。メトロバセサS.A.は1918年に設立され、スペインのマドリードに本拠を置く。

Metrovacesa S.A. 基礎のまとめ

Metrovacesa の収益と売上を時価総額と比較するとどうか。
MVC 基礎統計学
時価総額€1.62b
収益(TTM)€56.86m
売上高(TTM)€708.37m
28.6x
PER(株価収益率
2.3x
P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
MVC 損益計算書(TTM)
収益€708.37m
売上原価€528.83m
売上総利益€179.54m
その他の費用€122.68m
収益€56.86m

直近の収益報告

Dec 31, 2025

次回決算日

Jul 22, 2026

一株当たり利益(EPS)0.38
グロス・マージン25.35%
純利益率8.03%
有利子負債/自己資本比率30.7%

MVC の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

14.7%
現在の配当利回り
n/a
配当性向

MVC 配当は確実ですか?

MVC 配当履歴とベンチマークを見る
MVC 、いつまでに購入すれば配当金を受け取れますか?
Metrovacesa 配当日
配当落ち日May 20 2026
配当支払日May 22 2026
配当落ちまでの日数3 days
配当支払日までの日数1 day

MVC 配当は確実ですか?

MVC 配当履歴とベンチマークを見る

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/05/22 21:19
終値2026/05/22 00:00
収益2025/12/31
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Metrovacesa S.A. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。22

アナリスト機関
Ignacio RomeroBanco de Sabadell. S.A.
null nullBanco de Sabadell. S.A.
Mariano Miguel HidalgoBanco Santander